What is the equity of BioPlus Co this year?
BioPlus Co has equity of 127.82 B KRW this year.
BioPlus Co Equity 2024
BioPlus Co Equity
127.82 B KRW
Ticker
099430.KQ
ISIN
KR7099430001
In 2024, BioPlus Co's equity was 127.82 B KRW, a 12.85% increase from the 113.27 B KRW equity in the previous year.
BioPlus Co Aktienanalyse
What does BioPlus Co do?
BioPlus Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing BioPlus Co's Equity
BioPlus Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding BioPlus Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating BioPlus Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
BioPlus Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in BioPlus Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about BioPlus Co stock
What was the equity of BioPlus Co compared to the previous year?
The equity of BioPlus Co has increased/decreased by 12.85% increased compared to the previous year.
What impact does a high equity have on investors of BioPlus Co?
A high equity is advantageous for investors of BioPlus Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of BioPlus Co?
A low equity can be a risk for investors of BioPlus Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of BioPlus Co affect the company?
An increase in equity of BioPlus Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of BioPlus Co affect the company?
A reduction in equity of BioPlus Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of BioPlus Co?
Some factors that can affect the equity of BioPlus Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of BioPlus Co so important for investors?
The equity of BioPlus Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can BioPlus Co take to change the equity?
To change equity, BioPlus Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does BioPlus Co pay?
Over the past 12 months, BioPlus Co paid a dividend of 70 KRW . This corresponds to a dividend yield of about 1.39 %. For the coming 12 months, BioPlus Co is expected to pay a dividend of 80.58 KRW.
What is the dividend yield of BioPlus Co?
The current dividend yield of BioPlus Co is 1.39 %.
When does BioPlus Co pay dividends?
BioPlus Co pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioPlus Co?
BioPlus Co paid dividends every year for the past 4 years.
What is the dividend of BioPlus Co?
For the upcoming 12 months, dividends amounting to 80.58 KRW are expected. This corresponds to a dividend yield of 1.6 %.
In which sector is BioPlus Co located?
BioPlus Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioPlus Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioPlus Co from 5/1/2024 amounting to 70 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.
When did BioPlus Co pay the last dividend?
The last dividend was paid out on 5/1/2024.
What was the dividend of BioPlus Co in the year 2023?
In the year 2023, BioPlus Co distributed 70 KRW as dividends.
In which currency does BioPlus Co pay out the dividend?
The dividends of BioPlus Co are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioPlus Co
Our stock analysis for BioPlus Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioPlus Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.